UPM Institutional Repository

Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system


Citation

Dorniani, Dena and Hussein, Mohd. Zobir and Kura, Aminu Umar and Fakurazi, Sharida and Shaari, Abdul Halim and Ahmad, Zalinah (2013) Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system. Drug Design, Development and Therapy, 7. pp. 1015-1026. ISSN 1177-8881

Abstract

Background: Iron oxide nanoparticles are of considerable interest because of their use in magnetic recording tape, ferrofluid, magnetic resonance imaging, drug delivery, and treatment of cancer. The specific morphology of nanoparticles confers an ability to load, carry, and release different types of drugs. Methods and results: We synthesized super paramagnetic nanoparticles containing pure iron oxide with a cubic inverse spinal structure. Fourier transform infrared spectra confirmed that these Fe3O4 nanoparticles could be successfully coated with active drug, and thermogravimet-ric and differential thermogravimetric analyses showed that the thermal stability of iron oxide nanoparticles coated with chitosan and 6-mercaptopurine (FCMP) was markedly enhanced. The synthesized Fe3O4 nanoparticles and the FCMP nanocomposite were generally spherical, with an average diameter of 9 nm and 19 nm, respectively. The release of 6-mercaptopurine from the FCMP nanocomposite was found to be sustained and governed by pseudo-second order kinetics. In order to improve drug loading and release behavior, we prepared a novel nanocomposite (FCMP-D), ie, Fe3O4 nanoparticles containing the same amounts of chitosan and 6-mercaptopurine but using a different solvent for the drug. The results for FCMP-D did not demonstrate "burst release" and the maximum percentage release of 6-mercaptopurine from the FCMP-D nanocomposite reached about 97.7% and 55.4% within approximately 2,500 and 6,300 minutes when exposed to pH 4.8 and pH 7.4 solutions, respectively. By MTT assay, the FCMP nanocomposite was shown not to be toxic to a normal mouse fibroblast cell line. Conclusion: Iron oxide coated with chitosan containing 6-mercaptopurine prepared using a coprecipitation method has the potential to be used as a controlled-release formulation. These nanoparticles may serve as an alternative drug delivery system for the treatment of cancer, with the added advantage of sparing healthy surrounding cells and tissue.


Download File

[img]
Preview
PDF (Abstract)
Preparation and characterization of 6.pdf

Download (86kB) | Preview

Additional Metadata

Item Type: Article
Divisions: Faculty of Science
Faculty of Medicine and Health Science
Institute of Advanced Technology
DOI Number: https://doi.org/10.2147/DDDT.S43035
Publisher: Dove Medical Press
Keywords: 6-mercaptopurine; Controlled release; Cytotoxicity; Drug delivery; Superparamagnetic nanoparticles.
Depositing User: Umikalthom Abdullah
Date Deposited: 25 Aug 2014 05:11
Last Modified: 07 Oct 2015 08:52
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.2147/DDDT.S43035
URI: http://psasir.upm.edu.my/id/eprint/30185
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item